JP2008526935A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526935A5
JP2008526935A5 JP2007550830A JP2007550830A JP2008526935A5 JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5 JP 2007550830 A JP2007550830 A JP 2007550830A JP 2007550830 A JP2007550830 A JP 2007550830A JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5
Authority
JP
Japan
Prior art keywords
use according
drug
intended
wound
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526935A (ja
Filing date
Publication date
Priority claimed from GBGB0500643.2A external-priority patent/GB0500643D0/en
Application filed filed Critical
Publication of JP2008526935A publication Critical patent/JP2008526935A/ja
Publication of JP2008526935A5 publication Critical patent/JP2008526935A5/ja
Pending legal-status Critical Current

Links

JP2007550830A 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド Pending JP2008526935A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012165481A Division JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Publications (2)

Publication Number Publication Date
JP2008526935A JP2008526935A (ja) 2008-07-24
JP2008526935A5 true JP2008526935A5 (enExample) 2009-02-26

Family

ID=34224534

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007550830A Pending JP2008526935A (ja) 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Country Status (7)

Country Link
US (3) US20080139478A1 (enExample)
EP (2) EP2332566A1 (enExample)
JP (2) JP2008526935A (enExample)
AU (1) AU2006205696C1 (enExample)
CA (1) CA2594798A1 (enExample)
GB (1) GB0500643D0 (enExample)
WO (1) WO2006075138A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
RU2542471C2 (ru) * 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
EP2451780B1 (en) 2009-07-06 2013-06-19 AstraZeneca AB Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
EP2691515A2 (en) * 2011-03-31 2014-02-05 President and Fellows of Harvard College A unique population of regulatory t cells that regulate tissue regeneration and wound healing
US20160287744A1 (en) 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
CA2905182A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3206713A4 (en) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
CA2995120A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
MX9606537A (es) * 1994-07-05 1997-12-31 Steeno Res Group As Inmunomoduladores.
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Similar Documents

Publication Publication Date Title
AU2002334886B2 (en) Methods and compositions for treating dermal lesions
ES2426420T3 (es) Péptidos de queratina bioactivos
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
US20110160118A1 (en) Methods and compositions for treating oral and esophageal lesions
JP2022513223A5 (enExample)
US7538082B2 (en) Methods and compositions for treating oral and esophageal lesions
HRP20140616T1 (hr) Peptidni analog oksintomodulina
ES2818824T3 (es) Composiciones que comprenden una proteína de fusión de VIP-ELP para su uso en el tratamiento de fibrosis quística
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
WO2003093293A3 (en) Peptide antagonists of tgf-beta family members and therapeutic uses thereof
WO1999006440A8 (en) Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
TWI305778B (en) Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
WO2003018049A3 (en) Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
CA2825247A1 (en) Human lactoferrin derived peptides and their use
JP2009535330A5 (enExample)
WO2008113970A3 (en) Peptides
CN105451756A (zh) 在治疗马凡氏综合征及其相关病症中的血管紧张素肽
JP2008526935A (ja) 創傷治癒のためのil−10関連ペプチド
RU2011133224A (ru) Новые фармацевтические композиции
JP2007500133A5 (enExample)
CA2423004A1 (en) Peptide inhibitors of hiv entry
CN114349870B (zh) 一种兼具防粘连功效的重组抗菌肽及其制备方法和应用
WO2008070049A8 (en) Peptide and treatment for hiv-1 infection
US8853359B2 (en) Endokinin C/D-derived peptides
KR20160065351A (ko) 엔케팔린 변이체를 함유하는 상처 치료용 조성물